Multiple primary malignancies are defined as two or more different malignancies detected synchronously or metachronously in different organs of an individual patient. However, studies for the clinicopathologic features regarding multiple primary malignancies patients with hepatocellular carcinoma (HCC) are insufficient. In this study, we performed a retrospective study to investigate the clinicopathologic features for the HCC patients with multiple primary malignancies.
Introduction
Multiple primary malignancies are defined as two or more different malignancies detected synchronously or metachronously in different organs of an individual patient. However, studies for the clinicopathologic features regarding multiple primary malignancies patients with hepatocellular carcinoma (HCC) are insufficient. In this study, we performed a retrospective study to investigate the clinicopathologic features for the HCC patients with multiple primary malignancies.
Conclusion

Multiple primary malignancies in patients with HCC
Is it a poor prognosis factor for overall survival?
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Methods
The patients with multiple primary tumors have a relatively good prognosis mostly due to non-viral background liver and less invasive tumor characteristic. Also we could consider that there is a chance to detect malignancy earlier due to a screedning study and the clear etiopathogenesis is difficult to find, we could consider a genetic influence about tumor suppression. In this respect, we need a further study in the future. Between May 1997 and July 2016, 1043 HCC patients had been received radical surgical treatment including hepatectomy and liver transplantation in our institute. Among them 58 (5.6%) cases were diagnosed with extra-hepatic primary malignancies. The comparison between single primary HCC and multiple primary malignancies were performed. The clinicopathologic features including Age, Sex, HBs Ag (positive), HCV Antibody (positive), AFP(more than 400ng/ml), tumor size (more than 5cm), multiple tumor number, microvascular invasion, Edmondson grade (grade 3 and 4), cirrhosis (fibrosis stage 4), AJCC staging for HCC (stage 1).
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Results
The median follow up time is 53 months in the present study. Of the 58 ( 
